BioNTech SE - ADR vs Honeywell International Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Honeywell International Inc trades at $230.67 (market cap $72.93B). The key difference: Honeywell International Inc is far larger — about 3.1× BioNTech SE - ADR's market cap, and Honeywell International Inc pays a 1.22% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | HON | |
|---|---|---|
Market Cap | $23.31B | $72.93B |
Sector | Health | Industrials |
52-Week High | $119.34 | $248.79 |
52-Week Low | $83.89 | $188.14 |
Enterprise Value | $6.60B | $97.73B |
Dividend Yield | — | 1.22% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →